Close
Help
Need Help?



Meclizine: Safety and Efficacy in the Treatment and Prevention of Motion Sickness

Submit a Paper


Libertas Analytics


1300 Article Views

Publication Date: 08 May 2011

Type: Review

Journal: Clinical Medicine Insights: Therapeutics

Citation: Clinical Medicine Insights: Therapeutics 2011:3 179-183

doi: 10.4137/CMT.S6237

CMIt journal

652,506 Article Views

8,122,889 Libertas Article Views

More Statistics

Abstract

Motion sickness is a self-limiting but uncomfortable phenomenon experienced by many people. It is common during civilian travel and also among professionals during travel or military manoeuvres. Meclizine is a piperzine antihistamine that is effective for the prevention and treatment of motion sickness, particularly during mild civilian travel. It is well tolerated with few adverse effects and its oral dosage form is convenient for patients to take prior to exposure to motion as a preventative measure.


Downloads

PDF  (440.60 KB PDF format)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)


Sharing

Our Service Promise

  • Prompt Processing (Less Than 3 Weeks)
  • Fair & Comprehensive Peer Review
  • Professional Author Service
  • Leading Editors in Chief
  • Extensive Indexing
  • High Readership & Impact
  • What Your Colleagues Say

Quick Links

Follow Us We make it easy to find new research papers.
Email AlertsRSS Feeds
FacebookGoogle+Twitter
PinterestTumblrYouTube

SUBJECT HUBS
Our Testimonials
Publishing in Air, Soil and Water and Water Research was the best experience I have had so far in an academic context.  The review process was fair, quick and efficient.  I congratulate the team at Libertas Academica for a very well managed journal.
Magnus Karlsson (IVL Swedish Environmental Research Institute, Stockholm, Sweden) What Your Colleagues Say